Dia 2

      Hay Lugar Aun Para los Inhibidores GPIIbIIIa?

      Pedro Ureña Velásquez2014-08-08FACC FSCAI FACCPDirector Medicina Cardiovascular Asociada   

      Thromboprophylaxis with antiplatelet agents in patients with mechanical aortic valves

      Raúl García-Rinaldo2014-08-08MD, PhD, FACS Ponce School of Medicine, Ponce, PRMayaguez Medical Center, Mayaguez, PR

      Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy

      Igor F. Palacios2014-08-08Director of Interventional CardiologyMassachusetts General HospitalProfessor of MedicineHarvard Medical School

      Percutaneous Treatment of Mitral Regurgitation

      Igor F. Palacios2014-08-08Director of Interventional CardiologyMassachusetts General HospitalProfessor of MedicineHarvard Medical School

      Evaluation and Management of Asymptomatic Aortic Stenosis

      Augusto Pichard2014-08-08Director Innovation and Structural Heart Disease,  Vice Chair, Medstar Heart Institute, Medstar Washington Hospital Center. Professor of...

      TAVI: Present and Future Perspective

      Igor F. Palacios2014-08-08Director of Interventional CardiologyMassachusetts General HospitalProfessor of MedicineHarvard Medical School

      Manejo Endovascular de los Síndromes Agudos de la aorta torácica

      Jorge Mayol2014-08-08Servicio de Cardiología Intervencionista Centro Cardiológico Americano Montevideo - Uruguay